SELLAS Life Sciences Group (SLS) Earnings Date & Reports
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more
SLS is expected to report earnings to rise 75.00% to -10 cents per share on May 08
Q1'25
Est.
$-0.10
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.02
The last earnings report on March 20 showed earnings per share of -5 cents, beating the estimate of -10 cents. With 720.75K shares outstanding, the current market capitalization sits at 99.02M.